Results 201 to 210 of about 52,688 (314)

Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3

open access: yeseJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Background Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM) and a primary cause of disability in affected patients. Its pathogenesis is driven by an imbalance in bone remodeling, largely attributed to the overexpression of C‐C motif chemokine ligand 3 (CCL3). While both bortezomib and statins have been reported
Fujun Qu   +6 more
wiley   +1 more source

Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia. [PDF]

open access: yesCirc Genom Precis Med
Levy ME   +20 more
europepmc   +1 more source

Ablation of Ventricular Tachycardia Using the QDOT MICRO Ablation Catheter (VT‐MICRO Study)

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Catheter ablation is useful to treat patients with ventricular tachycardia. QDOT Micro catheter is a next generation catheter designed to provide more efficient lesion creation with an accurate myocardial substrate analysis. Microelectrode mapping allows detection of higher voltage electrograms compared to standard bipolar mapping and Pentaray mapping.
Antonio Di Monaco   +6 more
wiley   +1 more source

Coronary Artery Disease and Lipoprotein Abnormalities in Patients with Heterozygous Familial Hypercholesterolemia Associated with Diabetes Mellitus or Impaired Glucose Tolerance

open access: diamond, 1992
Koji Yanagi   +12 more
openalex   +2 more sources

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia [PDF]

open access: gold, 2019
Mary P. McGowan   +3 more
openalex   +1 more source

Bile Acid Binding Resins Improve Glucagon Receptor Agonist‐Mediated Weight Loss in Diet‐Induced Obese Mice

open access: yesObesity, Volume 34, Issue 2, Page 428-438, February 2026.
ABSTRACT Objective Glucagon‐receptor (GCGR) agonism reguglates bile acid (BA) metabolism and promotes weight loss in diet‐induced obese (DIO) mice. Thus, we hypothesized that BA signaling contributes to GCGR‐stimulated weight loss. Methods To test this hypothesis, we utilized BA‐binding resins (BARs; colesevelam [Colsv] and cholestyramine [Cstyr]) to ...
Teayoun Kim   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy